5208 related articles for article (PubMed ID: 6239683)
1. Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice.
Kedar E; Chriqui-Zeira E; Mitelman S
Cancer Immunol Immunother; 1984; 18(2):126-34. PubMed ID: 6239683
[TBL] [Abstract][Full Text] [Related]
2. In vitro induction of cell-mediated immunity to murine leukemia cells. II. cytotoxic activity in vitro and tumor-neutralizing capacity in vivo of anti-leukemia cytotoxic lymphocytes generated in macrocultures.
Kedar E; Schwartzbach M; Raanan Z; Hefetz S
J Immunol Methods; 1977; 16(1):39-58. PubMed ID: 68086
[TBL] [Abstract][Full Text] [Related]
3. In vitro elicitation of cytotoxic response against a nonimmunogenic murine tumor by allosensitization.
Leshem B; Gotsman B; Kedar E
Cancer Immunol Immunother; 1984; 17(2):117-23. PubMed ID: 6235909
[TBL] [Abstract][Full Text] [Related]
4. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
5. In vitro induction of cell-mediated immunity to murine leukemia cells. III. Effect of methanol extraction residue fraction of BCG on the generation of cytotoxic lymphocytes against leukemia.
Kedar E; Nahas F; Unger E; Weiss DW
J Natl Cancer Inst; 1978 May; 60(5):1097-106. PubMed ID: 147948
[TBL] [Abstract][Full Text] [Related]
6. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. III. Stimulation of syngeneic antitumor responses by subcellular fractions and molecular species of Moloney virus-induced tumors in CBA and A mice.
Ahituv A; Naor D; Sharon R; Tarcic N; Klein BY
Cancer Immunol Immunother; 1982; 14(1):16-26. PubMed ID: 6186365
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of cytotoxic effector cells against human neoplasms. I. Sensitization conditions and effect of cryopreservation on the induction and expression of cytotoxic responses to allogeneic leukemia cells.
Kedar E; Raanan Z; Kafka I; Holland JF; Bekesi G; Weiss DW
J Immunol Methods; 1979; 28(3-4):303-19. PubMed ID: 383844
[TBL] [Abstract][Full Text] [Related]
9. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
Cheever MA; Greenberg PD; Fefer A
Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.
Leshem B; Kedar E
J Exp Med; 1990 Apr; 171(4):1057-71. PubMed ID: 2139097
[TBL] [Abstract][Full Text] [Related]
11. Isolated soluble fractions from the murine B16 melanoma induce primary in vitro syngeneic antitumor responses.
Klein BY; Frenkel S; Naor D
Cancer Immunol Immunother; 1984; 18(3):195-202. PubMed ID: 6239687
[TBL] [Abstract][Full Text] [Related]
12. Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction.
Suzuki R; Suzuki S; Igarashi M; Kumagai K
J Immunol; 1986 Sep; 137(5):1564-72. PubMed ID: 2427574
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
Itoh K; Tilden AB; Balch CM
Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
Mukherji B; Nashed AL; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
[TBL] [Abstract][Full Text] [Related]
15. The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.
Hancock EJ; Kilburn DG
Cancer Immunol Immunother; 1982; 14(1):54-8. PubMed ID: 6819082
[TBL] [Abstract][Full Text] [Related]
16. In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets.
Peppoloni S; Mathieson BJ; Herberman RB; Overton RW; Gorelik E
Cancer Immunol Immunother; 1987; 24(1):49-56. PubMed ID: 2949833
[TBL] [Abstract][Full Text] [Related]
17. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
Uchida A; Moore M
Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
[TBL] [Abstract][Full Text] [Related]
18. [Cytotoxicity of lymphocytes sensitized by autologous tumor cells in vitro, against autologous lung cancer cell lines].
Inaba H; Kobayashi S; Okada S; Fujimura S; Nakata T
Nihon Geka Gakkai Zasshi; 1990 Apr; 91(4):515-23. PubMed ID: 2142996
[TBL] [Abstract][Full Text] [Related]
19. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
20. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
